Showing results (491-500 of 652) with videos related to

Sort By:
Pageof 66
BMJ Medicine|November 3, 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trialKarine Lacombe, Thomas Hueso, Raphael Porcher, et al.
Haematologica|August 5, 2018
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trialJuliette Lambert, Cécile Pautas, Christine Terré, et al.
Genes, Chromosomes & Cancer|November 20, 2013
Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic indexClémentine Sarkozy, Christine Terré, Fabrice Jardin, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2016
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?Damien Pouessel, Sylvie Chevret, Frédéric Rolland, et al.
Experimental Hematology & Oncology|December 12, 2012
French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemiaPascale Trioche, Brigitte Nelken, Gérard Michel, et al.
Blood|May 15, 2004
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 studySylvie Castaigne, Sylvie Chevret, Eric Archimbaud, et al.
Annals of Hematology|November 5, 2024
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemiaCécile Tomowiak, Stéphanie Poulain, Morgane Nudel, et al.
Journal of Neuroendocrinology|June 22, 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECISTLouis de Mestier, Matthieu Resche-Rigon, Clarisse Dromain, et al.
Journal of Neurointerventional Surgery|August 27, 2025
Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN studyMikaël Mazighi, Jerome Lambert, Benjamin Gory, et al.
Pageof 66